| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
26,020,000 |
| Market
Cap: |
176.42(M) |
| Last
Volume: |
6,675 |
Avg
Vol: |
6,657 |
| 52
Week Range: |
$6.48 - $11.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fennec Pharmaceuticals is a biopharmaceutical company focused on the development of PEDMARK™ (sodium thiosulfate anhydrous injection) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. Co. has licensed from Oregon Health & Science University intellectual property rights for the use of PEDMARK™ as a chemoprotectant and is developing PEDMARK™ as a protectant against the hearing loss caused by platinum-based anti-cancer agents in children.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
41,667 |
41,667 |
41,667 |
41,667 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
384,683 |
419,729 |
479,718 |
532,549 |
| Total Sell Value |
$3,266,840 |
$3,639,968 |
$4,139,278 |
$4,642,390 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
18 |
22 |
30 |
38 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Clark John Smith Ii |
10% Owner |
– – • |
2010-06-08 |
4 |
S |
$0.00 |
$0 |
I/I |
(41,504,000) |
200,000,000 |
|
- |
|
| Clark John Smith Ii |
10% Owner |
– – • |
2010-04-30 |
4 |
B |
$0.00 |
$0 |
I/I |
200,000,000 |
241,504,000 |
1.42 |
- |
|
| Clark John Smith Ii |
10% Owner |
– – • |
2010-02-22 |
4/A |
S |
$0.00 |
$0 |
I/I |
(0) |
41,504,000 |
|
- |
|
| Andrade Robert |
Vice PresidentOfficer |
• • – |
2009-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
780,100 |
|
- |
|
| Raykov Rosty |
Chief Executive OfficerOfficer |
• • – |
2009-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000,000 |
|
- |
|
| Butts Robert W |
Director |
– • – |
2007-04-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
41,504,000 |
|
- |
|
| Breen William G |
Director |
– • – |
2007-04-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
687,064 |
|
- |
|
| Breen William G |
Director |
– • – |
2007-04-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
680,717 |
|
- |
|
| Peters William P |
Chairman and CEOOfficer |
• • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
165,982 |
|
- |
|
| Norris Robin J |
President & COOOfficer |
• • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,100 |
|
- |
|
| Morand Peter |
Director |
– • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
45,000 |
|
- |
|
| Morand Peter |
Director |
– • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| Mermelstein Fred H |
Director |
– • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,327,819 |
|
- |
|
| Mermelstein Fred H |
Director |
– • – |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,591 |
|
- |
|
| Clark John Smith Ii |
10% Owner |
– – • |
2007-02-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
41,504,000 |
|
- |
|
290 Records found
|
|
Page 12 of 12 |
|
|
0.07 (1.02%) 
